According to ACC/AHA guidelines, women with hypertension who become pregnant, or are planning to become pregnant, should be transitioned to methyldopa, nifedipine, and/or labetalol. Women with hypertension who become pregnant should not be treated with ACE inhibitors, ARBs, or direct renin inhibitors. Lifestyle modifications are generally sufficient for the management of pregnant women with stage 1 hypertension who are at low risk for cardiovascular complications during pregnancy.
Simultaneous use of an ACE inhibitor, ARB, and/or renin inhibitor is possibly harmful and is not recommended among patients with hypertension. Beta-blockers are no longer considered first-line therapy for hypertension, but these agents can be used in cases with compelling indications aside from hypertension, such as systolic heart failure.
According to ACC/AHA guidelines, aldosterone antagonists are preferred agents in primary aldosteronism and resistant hypertension.
This Fast Five Quiz was excerpted and adapted from the Medscape Drugs & Diseases article Hypertension.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Yasmine S. Ali. Fast Five Quiz: Hypertension Practice Essentials - Medscape - Mar 19, 2020.